Standard BioTools Inc.
LAB
$0.90
-$0.06-6.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 155.59% | -3.67% | -28.53% | 23.59% | -26.48% |
| Total Depreciation and Amortization | 231.00% | -60.02% | -4.24% | -66.61% | 2,888.62% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -50.36% | 34.92% | 7.62% | 1,549.29% | -104.85% |
| Change in Net Operating Assets | -6,666.88% | -56.23% | 106.90% | -294.57% | 174.98% |
| Cash from Operations | 94.64% | -7.42% | 31.75% | -115.40% | 49.55% |
| Capital Expenditure | 46.28% | 53.05% | 62.66% | -49.44% | -49.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -30.53% | -119.72% | 49.36% | -35.46% | 206.51% |
| Cash from Investing | -20.34% | -124.29% | 88.07% | -43.15% | 183.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | 672.06% |
| Repurchase of Common Stock | -12.50% | 44.00% | -334.78% | -2.22% | 35.71% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 653.57% | -203.70% | 334.78% | 99.92% | -2,725,900.00% |
| Foreign Exchange rate Adjustments | 50.74% | -125.76% | 120.73% | 233.71% | 34.56% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 70.17% | -477.58% | 150.39% | 64.41% | 27.12% |